PGP and cancer: Furthermore, Bortolozzi et al. [46] synthesized and evaluated new ecdysteroid derivatives as P-gp inhibitors in two different resistant cell lines (CEMVbl100 and LoVoDoxo) and one cancer cell line (medulloblastoma).